Madhavi Vemireddy

Digital Content

We use cookies to enhance your browsing experience, serve personalized ads or content, and analyze our traffic. We’ll assume you’re ok with this, but you can opt out if you wish. See our 

Footer

2025 Event

Column Name Goes Here

Footer V2

2024 Event

Event Global

New HLTH Insights Programs

Become a Hosted Buyer

Become a Sponsor/Exhibitor

Apply for Media Pass

Promote Your Presence

2023 Event

Event Global Footer

Startup Opportunities

Hotel

2022 Event

LLC Global

2020 Event

2021 Event

LLC Menu Official

LLC Menu

Managing Director

Margaret Anderson

Madhavi Vemireddy, MD is Cleo’s CEO, having previously served as Cleo’s Chief Clinical Officer. Madhavi is board-certified in Internal Medicine and has over 24 years of experience in advanced clinical analytics, population health programs, and digital health products. At ActiveHealth Management (CVS Health Company), Madhavi served as CMO and Head of Product. She led a multidisciplinary team of physicians, pharmacists, nurses, program design and product managers focused on the development and integration of clinical analytics with clinical programs and digital platforms to help drive patient engagement and quality improvement across the spectrum of health (end of life care, complex case management, condition and lifestyle management) with proven cost savings. The proprietary and patented clinical analytics suite called CareEngine delivered evidence-based recommendations and improvement in care for over 22M Aetna and multi-payer members and still remains a part of the CVS Health evidence-based analytics suite.

Madhavi joined Cleo through the CareTribe acquisition, where she was the co-founder and COO. At CareTribe, Madhavi applied her population health experience to support family caregivers, irrespective of the age or condition of their loved one(s). As Cleo’s CEO, Madhavi leads a mission-driven team dedicated to building a culture and care ecosystem where caregivers can get the support needed at work and at home. Cleo’s analytical, digital and expert service support model is rooted in a population health framework and focused on driving better family health outcomes.

Madhavi has a personal story that informs her work. As a family caregiver, she is part of the “Sandwich Generation,” caring both for her two children and for her parents. Her eldest son is on the Autism Spectrum with significant motor and speech delays. Her personal experience caring for him helped identify the gaps we have in our healthcare ecosystem for supporting family caregivers.

Margaret is a Managing Director with Deloitte Consulting where she brings biomedical program, policy, and patient engagement experience to strategy projects in the Federal Health and nonprofit area. She leads high-impact scientific projects focused on public-private partnerships, and data and business strategy. She is also Chief Marketing Officer of the Federal Health Sector at Deloitte.

She advanced several movements in her career, from patient centricity to women’s health research, to HIV/AIDS and genetics, and pandemic response. She joined Deloitte from FasterCures, a center of the Milken Institute. As Executive Director of FasterCures, she drove programs advancing the science of patient input, examining the metrics for consortia, and policy related to federal research and regulatory paradigms. She led HIV/AIDS strategy and other public health issues at the American Public Health Association and in a consulting capacity for CDC’s HIV/AIDS programs. She began her career as a Project Director at the Congressional Office of Technology Assessment looking at the impact of biotechnology and genetics on the economy and society. 

Margaret was a founding board member and past president of the Alliance for a Stronger FDA, and the NIH National Center for Advancing Translational Sciences Advisory Council and the Cures Acceleration Network Review Board. She served on boards for National Health Council, United for Medical Research, Food and Drug Administration's Science Board, Science Looking Forward Committee, and the National Academy of Medicine’s Forum on Drug Discovery, Development and Translation. She serves on the Boards of Act for NIH, Allen Institute, FasterCures, Friends of Cancer Research and the National Cancer Advisory Board. She attended University of Maryland and majored in Political Science, and holds a Master’s in Science Policy from the George Washington University. 


As NASCO’s President & CEO, Lori Logan works closely with leaders across health plans and NASCO to deliver a holistic portfolio of healthcare administrative products and services that put health plans in control of innovation, better member experiences, and driving affordability.

With over 30 years of experience as a healthcare executive, Lori’s expertise includes a focus on healthcare product innovation, product management, strategy and healthcare go-to-market strategies across both payer and provider segments. Her passion to improve and cure healthcare drives her talent to ensure a seamless flow within the industry. Lori has held leadership positions at athenahealth, UnitedHealthcare, Geneia (a subsidiary of Capital Blue Cross), Cigna, TriZetto, McKesson, and Choicelinx Corporation. Over the years, her achievements have included boosting brand awareness and loyalty, capturing market share, and increasing profitability. Her relentless focus on results and pragmatic sense has set a precedent, as she continues to lead and make an impact within the healthcare industry.

Lori has been recognized with the CEO Pinnacle Award for her innovative accomplishments while serving as President of TriZetto, and she was also awarded the Healthcare Advantage Consumer Outreach & Communications Award by Thomson Reuters. She received a Bachelor of Science in Business Administration from Regis University and a Master of Science in Computer Information Systems from Boston University.


President and CEO

Lori Logan

Dr. Madhavi Vemireddy, MD